Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Treatment and Management of Schizophrenia in Europe
2010-020185-19Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amisulpride, olanzapine and clozapine in schizophrenia, schizophreniform disorder and schizoaffective disorder (4 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Remission at end of Phase I, Remission at end of Phase II and 1 more. Started Aug 2010; status: completed.
02
Drugs
amisulprideolanzapineclozapine
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on 2010-020185-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020185-19.